This study was performed to investigate the platelet aggregation alterations in platelet-rich plasma (PRP) samples of children with Helicobacter pylori (H pylori) infection. Platelet aggregation induced by adenosine diphosphate (ADP), collagen, ristocetin, or epinephrine was studied with photometric aggregometry in 30 patients before and after eradication therapy and in a control group including 15 children. The pretreatment mean maximum aggregation values and slope were significantly lower (P < .0001) in the study group at 10 μmol/L concentrations of ADP (ADP-like defect). The maximum aggregation values and slope revealed no significant differences (P > 0.05) between the study group after therapy and the control group. We concluded that H pylori infection may cause dysfunction of platelets in children and can be reversed by H pylori eradication therapy. Further studies should be carried out to determine the mechanisms of platelet dysfunction in children with H pylori infection.
The EUROGAST Study Group.Epidemiology of, and risk factors for Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. Gut. 1994;34(12):1672-1676.
Kato S., Nishino Y., Ozawa K., et al. The prevalence of Helicobacter pylori in Japanese children with gastritis or peptic ulcer disease. J Gastroenterol. 2004;39(8): 734-738.
4.
Uemura N., Okamoto S.Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer in Japan. Gastroenterol Clin North Am. 2000;29(4):819-827.
5.
Cremonini F. , Di Caro S., Delgado-Aros S., et al. Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2003; 18(3):279-289.
6.
Emilia G., Longo G., Luppi M., et al. Helicobacter pylori eradication can induce platelet recovery in idiopathic thrombocytopenic purpura. Blood. 2001;97(3):812-814.
7.
Kurekci AE, Atay AA, Sarıcı SU, et al. Is there a relationship between childhood Helicobacter pylori infection and iron deficiency anemia? J Trop Pediatr. 2005; 51(3):166-169.
8.
Danesh J., Youngman L., Clark S., et al. For the International Studies of Infarct Survival (ISIS) Collaborative Group: Helicobacter Pylori Infection and Early Onset Myocardial Infarction: Case Control and Sibling Pairs Study. Br Med J. 1999;319(7218): 1157-62.
9.
Gunn M., Stephens J., Thompson J., et al. Significant association of cag A positive Helicobacter pylori strains with risk of premature myocardial infarction. Heart . 2000;84(3):267-271.
10.
Ossei-Gerning N., Moayyedi P., Smith S., et al. Helicobacter pylori infection is related to atheroma in patients undergoing coronary angiography. Cardiovasc Res. 1997;35(1):120-124.
11.
Pietroiusti A., Diomedi M., Silvestrini M., et al. Cytotoxinassociated gene-A positive Helicobacter pylori strains are associated with atherosclerotic stroke. Circulation. 2002;106(5): 580-584.
12.
Rupprecht HJ , Blankenberg S., Bickel C., et al. Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease. Circulation. 2001;104(1):25-31.
13.
Aguejouf O. , Mayo K., Monteiro L., Doutremepuich F., Doutremepuich C., Megraud F.Increase of arterial thrombosis parameters in chronic Helicobacter pylori infection in mice. Thromb Res . 2003;108(4):245-248.
14.
Marchetti M. , Aricò B., Burroni D., Figura N., Rappuoli R., Ghiara P.Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science. 1995;267(5204): 1655-1658.
15.
Elizalde IJ , Gomez J., Panes J., et al. Platelet activation in mice and human Helicobacter pylori infection. J Clin Invest. 1997;100(5): 996-1005.
16.
Byrne MF, Kerrigan SW, Corcoran PA, et al. Helicobacter pylori binds von Willebrand factor and interacts with GP1b to induce platelet aggregation. Gastroenterology . 2003;124(7):1846-1854.
17.
Kato S., Konno M., Maisawa S., et al. Results of triple eradication therapy in Japanese children: a retrospective multicenter study. J Gastroenterol. 2004;39(9):838-843.
18.
Ozturk E., Yesilova Z., Ilgan S., et al. A new, practical, low-dose 14C-urea breath test for the diagnosis of Helicobacter pylori infection: clinical validation and comparison with the standard method. Eur J Nucl Med Mol Imaging. 2003;30(11):1457-1462.
19.
Munsterhjelm E., Niemi TT, Syrjälä MT, Ylikorkala O., Rosenberg PHPropacetamol augments inhibition of platelet function by diclofenac in volunteers. Br J Anaesth. 2003;91(3): 357-362.
20.
Kurekci AE, Atay AA, Sarící SU, Zeybek C., Köseoğlu V., Ozcan O.Effect of iron therapy on the whole blood platelet aggregation in infants with iron deficiency anemia. Thromb Res. 2000 ; 97(5):281-285.
21.
Naimushin YA , Mazurov AVvon Willebrand factor can support platelet aggregation via interaction with activated GPIIb-IIIa and GPIb. Platelets. 2004;15(7): 419-425.
22.
Zhou L., Schmaier AHPlatelet aggregation testing in platelet-rich plasma: description of procedures with the aim to develop standards in the field. Am J Clin Pathol. 2005;123(2):172-183.
23.
Radomski MW , Palmer RM, Moncada S.Characterization of the L-arginine:nitric oxide pathway in human platelets. Br J Pharmacol. 1990;101(2):325-328.
24.
Fu S., Ramanujam KS, Wong A., et al. Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis . Gastroenterology. 1999;116(6):1319-1329.
25.
Gobert AP, Mersey BD, Cheng Y., Blumberg DR, Newton JC, Wilson KTCutting edge: urease release by Helicobacter pylori stimulates macrophage inducible nitric oxide synthase. J Immunol. 2002;168(12): 6002-6006.
26.
Chang FY, Chen CY, Lu CL, Luo JC, Lu RH, Lee SDResponse of blood endothelin-1 and nitric oxide activity in duodenal ulcer patients undergoing Helicobacter pylori eradication. World J Gastroenterol. 2005;11(7): 1048-1051.
27.
Almqvist P. , Kuenzig M., Schwartz SIEffect of naloxone on endotoxin-induced pulmonary platelet sequestration. Acta Chir Scand. 1983 ;149(1):23-26.
28.
Itoh H., Cicala C., Douglas GJ, Page CPPlatelet accumulation induced by bacterial endotoxin in rats. Thromb Res. 1996;83(6): 405-419.
29.
Matera C., Falzarano C., Berrino L., Rossi F.Effects of tetanus toxin, Salmonella typhimurium porin, and bacterial lipopolysaccharide on platelet aggregation. J Med. 1992;23(5): 327-338.
30.
Sheu JR, Hsiao G., Lee C., et al. Antiplatelet activity of Staphylococcus aureus lipoteichoic acid is mediated through a cyclic AMP pathway. Thromb Res . 2000; 99(3):249-258.
31.
Sheu JR, Hung WC, Kan YC, Lee YM, Yen MHMechanisms involved in the antiplatelet activity of Escherichia coli lipopolysaccharide in human platelets. Br J Haematol. 1998; 103(1):29-38.
32.
Sheu JR, Hung WC, Su CH, et al. The antiplatelet activity of Escherichia coli lipopolysaccharide is mediated trough a nitric oxide/cyclic GMP pathway. Eur J Haematol. 1999;62(5): 317-326.
33.
Ameriso SF, Fridman AF, Leiguarda RC, Sevlever GEDetection of Helicobacter pylori in human carotid atherosclerotic plaques . Stroke. 2001;32(2):385-391.
34.
Farsak B., Yıldırır A., Akyön Y., et al. Detection of Chlamydia pneumoniae and Helicobacter pylori DNA in human atherosclerotic plaques by PCR. J Clin Microbiol. 2000;38(12): 4408-4411.
35.
Kalia N., Jacob S., Brown NJ, Reed MW, Morton D., Bardhan KDStudies on gastric mucosal microcirculation. 2. Helicobacter pylori water soluble extracts induce platelet aggregation in the gastric mucosal microcirculation in vivo. Gut. 1997;41(6):748-752.
36.
Corcoran PA , Atherton JC, Kerrigan SW, et al. The effect of different strains of Helicobacter pylori on platelet aggregation. Can J Gastroenterol . 2007;21(6): 367-370.
